There are 2949 resources available
LBA41 - LEAP-005: Phase II study of lenvatinib (len) plus pembrolizumab (pembro) in patients (pts) with previously treated advanced solid tumours
Presenter: Zarnie Lwin
Session: Proffered Paper - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1019O - Phase I studies of Sym021, an anti-PD-1 antibody, alone and in combination with Sym022 (anti-LAG-3) or Sym023 (anti-TIM-3)
Presenter: Nehal Lakhani
Session: Proffered Paper - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
Supporting parents with children who have cancer
Presenter: Johan De Munter
Session: EONS13: Supporting informal carers
Resources:
Slides
Webcast
How to support an informal caregiver as a nurse
Presenter: Yvonne Becque
Session: EONS13: Supporting informal carers
Resources:
Slides
Webcast
The Lived Experience of the Informal Carer for end of life cancer patients
Presenter: Antonis Tryphonos
Session: EONS13: Supporting informal carers
Resources:
Slides
Webcast
Q&A live discussion
Presenter: Amanda Drury
Session: EONS13: Supporting informal carers
Resources:
Webcast
Invited Discussant 1619O and LBA67
Presenter: Javier Martin Broto
Session: Proffered Paper - Sarcoma
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Winette Van Der Graaf
Session: Proffered Paper - Sarcoma
Resources:
Webcast
1619O - High clinical benefit rates of single agent pembrolizumab in selected rare sarcoma histotypes: First results of the AcSé Pembrolizumab study
Presenter: Jean-Yves Blay
Session: Proffered Paper - Sarcoma
Resources:
Abstract
Slides
Webcast
LBA67 - TRAMUNE, a phase Ib study combining trabectedin and durvalumab, results of the expansion cohort in patients with advanced pretreated soft tissue sarcomas
Presenter: Maud Toulmonde
Session: Proffered Paper - Sarcoma
Resources:
Abstract
Slides
Webcast